Eeek! It’s time for Drug Channels’ Halloween roundup of terrifying tales to share with your ghoulish fiends. This month’s tricks and treats:
- Spooky! Blue Shield of California frightens away the gross-to-net bubble with its Humira biosimilar strategy
- Vampiric! Prior authorization sinks its fangs into providers’ time
- Wicked! How the IRA will put a stake through specialty physician practices
- Eerie! Google’s monstrous AI podcasts leave me petrified
- Zoinks! Join the vampire hunters at Drug Channels Institute
Plus, Dr. Glaucomflecken tells us a frightening tale of copayments.
P.S. Stretch out your arms and join the ever-growing zombie horde who shamble after me on LinkedIn. You’ll find my ghostly rantings along with commentary from the undead hordes in the DCI community.
Read more »
